activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	631773	CHEMBL701630	Selectivity towards Protein kinase, ILK1	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084838	>	Selectivity		500.0	CHEMBL5247	Homo sapiens	Selectivity		500.0
	631773	CHEMBL701630	Selectivity towards Protein kinase, ILK1	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084838	>	Selectivity		500.0	CHEMBL5247	Homo sapiens	Selectivity		500.0
Not Active	3446224	CHEMBL1244364	Inhibition of ILK	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		IC50			CHEMBL5247	Homo sapiens	IC50		
Active	6360045	CHEMBL1832059	Inhibition of ILK in human PC3 cells assessed as decrease in GSK3-beta phosphorylation by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Active	6360046	CHEMBL1832060	Inhibition of ILK in human MDA-MB-231 cells assessed as decrease in GSK3-beta phosphorylation by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Active	6360047	CHEMBL1832061	Inhibition of ILK in human PC3 cells assessed as decrease in MLC phosphorylation by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Active	6360048	CHEMBL1832062	Inhibition of ILK in human MDA-MB-231 cells assessed as decrease in MLC phosphorylation by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Dose-dependent effect	6360053	CHEMBL1832067	Inhibition of human ILK activity assessed myelin basic protein phosphorylation by radiometric kinase assay in the presence of [gamma 32P]ATP	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
	6360054	CHEMBL1832067	Inhibition of human ILK activity assessed myelin basic protein phosphorylation by radiometric kinase assay in the presence of [gamma 32P]ATP	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
Dose-dependent effect	6360104	CHEMBL1832785	Inhibition of ILK in human PC3 cells assessed as decrease in phosphorylated ERK1/2 concentration by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Dose-dependent effect	6360105	CHEMBL1832786	Inhibition of ILK in human PC3 cells assessed as decrease in phosphorylated p38 concentration by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Not Active	6360106	CHEMBL1832787	Inhibition of ILK in human PC3 cells assessed as decrease in phosphorylated JNK concentration by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Not Active	6360107	CHEMBL1832788	Inhibition of ILK in human PC3 cells expressing constitutively active ILK assessed as decrease in phosphorylated ERK1/2 concentration by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Not Active	6360108	CHEMBL1832789	Inhibition of ILK in human PC3 cells expressing constitutively active ILK assessed as decrease in phosphorylated p38 concentration by Western blot analysis	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
	8004432	CHEMBL1943604	Inhibition of human ILK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	8004433	CHEMBL1943604	Inhibition of human ILK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	8004434	CHEMBL1943604	Inhibition of human ILK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	8004435	CHEMBL1943604	Inhibition of human ILK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	12183878	CHEMBL2211509	Inhibition of ILK	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5247	Homo sapiens	pIC50		5.0
	13436458	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436459	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436460	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436461	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436462	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436463	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436464	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436465	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436466	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436467	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436468	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	13436469	CHEMBL2422428	Inhibition of ILK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	15228441	CHEMBL3419802	Binding affinity to GST-tagged PH domain of ILK (unknown origin) by surface Plasmon resonance spectroscopy	B	Cc1c(O)cc2c(c1C)O[C@](C)(CCCC(C)C)CC2		CHEMBL3414669	=	Kd	nM	8700.0	CHEMBL5247	Homo sapiens	Kd	uM	8.7
	15228442	CHEMBL3419802	Binding affinity to GST-tagged PH domain of ILK (unknown origin) by surface Plasmon resonance spectroscopy	B	Cc1c(S(N)(=O)=O)cc2c(c1C)OC(C)(CCCC(C)C)CC2		CHEMBL3414686	=	Kd	nM	6200.0	CHEMBL5247	Homo sapiens	Kd	uM	6.2
	15228443	CHEMBL3419802	Binding affinity to GST-tagged PH domain of ILK (unknown origin) by surface Plasmon resonance spectroscopy	B	CC(C)CCCC1(C)CCc2cc(S(N)(=O)=O)cc(Br)c2O1		CHEMBL3414688	=	Kd	nM	13100.0	CHEMBL5247	Homo sapiens	Kd	uM	13.1
	16368349	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1Nc1ccccc1		CHEMBL3730447	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	uM	1.0
	16368350	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CCOC(=O)c1nnsc1Nc1ccccc1		CHEMBL3732509	=	IC50	nM	16000.0	CHEMBL5247	Homo sapiens	IC50	uM	16.0
	16368351	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	O=C(O)c1nnsc1Nc1ccccc1		CHEMBL3729907	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368352	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1Nc1ccc(Br)cc1		CHEMBL3727852	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368980	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	COc1ccc(Nc2snnc2C(N)=O)cc1		CHEMBL3728957	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368981	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CCOC(=O)Nc1snnc1C(N)=O		CHEMBL3727744	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368982	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1NC12CC3CC(CC(C3)C1)C2		CHEMBL3731506	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368983	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1NC1CCCCC1		CHEMBL3728317	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368984	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1Nc1cccc2ccccc12		CHEMBL3732293	=	IC50	nM	19000.0	CHEMBL5247	Homo sapiens	IC50	uM	19.0
	16368985	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1NCc1ccccc1		CHEMBL3730492	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368986	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NC(=O)c1nnsc1NC(=O)c1ccccc1		CHEMBL3732197	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368987	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CCNc1snnc1C(N)=O		CHEMBL3729546	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368988	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CCCCCCNc1snnc1C(N)=O		CHEMBL3730411	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368989	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CN(c1ccccc1)c1snnc1C(N)=O		CHEMBL3727714	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368990	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CC(=O)NC(=O)c1nnsc1Nc1ccccc1		CHEMBL3729909	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
	16368991	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	NCc1nnsc1Nc1ccccc1		CHEMBL3731081	>	IC50	nM	20000.0	CHEMBL5247	Homo sapiens	IC50	uM	20.0
Not Determined	16368992	CHEMBL3734081	Inhibition of full length recombinant GST-tagged ILK (unknown origin) expressed in baculovirus infected insect Sf9 cells using CKRRRLASLR as substrate incubated for 15 mins by scintillation counting analysis in presence of radiolabelled phosphate	B	CCCCCCCCCCCCCCN(c1ccccc1)c1snnc1C(N)=O		CHEMBL3732010		IC50			CHEMBL5247	Homo sapiens	IC50		
	16369952	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc2nc(-c3c(N)n[nH]c3NCCc3cnc[nH]3)sc2c1		CHEMBL3685731	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
	16369953	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccc(F)cc4)n[nH]c3N)nc2cc1F		CHEMBL3685649	=	IC50	nM	2400.0	CHEMBL5247	Homo sapiens	IC50	uM	2.4
	16369954	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4cccc([N+](=O)[O-])c4)n[nH]c3N)nc2cc1F		CHEMBL3685648	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16369955	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4cccc(F)c4)n[nH]c3N)nc2cc1F		CHEMBL3685647	=	IC50	nM	2300.0	CHEMBL5247	Homo sapiens	IC50	uM	2.3
	16369956	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3C3CC3c3ccccc3)nc2cc1F		CHEMBL3685646	=	IC50	nM	2100.0	CHEMBL5247	Homo sapiens	IC50	uM	2.1
	16369957	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccccc4F)n[nH]c3N)nc2cc1F		CHEMBL3639845	=	IC50	nM	4000.0	CHEMBL5247	Homo sapiens	IC50	uM	4.0
	16369958	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(Nc2ccc(SNc3nccs3)cc2)c1-c1nc2ccccc2s1		CHEMBL3730661	=	IC50	nM	3500.0	CHEMBL5247	Homo sapiens	IC50	uM	3.5
	16369959	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCCC(=O)O)c1-c1nc2ccccc2s1		CHEMBL3685644	=	IC50	nM	4300.0	CHEMBL5247	Homo sapiens	IC50	uM	4.3
	16369960	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCCCO)c1-c1nc2ccccc2s1		CHEMBL3685643	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	uM	1.7
	16369961	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(CCCCO)c1-c1nc2ccccc2s1		CHEMBL3685642	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	uM	1.0
	16369962	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2c(F)cccc2s1		CHEMBL3685641	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16369963	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)cc1		CHEMBL3685640	=	IC50	nM	3400.0	CHEMBL5247	Homo sapiens	IC50	uM	3.4
	16369964	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)c1		CHEMBL1368744	=	IC50	nM	3300.0	CHEMBL5247	Homo sapiens	IC50	uM	3.3
	16369965	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CCc1cc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)cc1O		CHEMBL3685639	=	IC50	nM	1900.0	CHEMBL5247	Homo sapiens	IC50	uM	1.9
	16369966	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CNc3cccc(S(N)(=O)=O)c3)cc2s1		CHEMBL3685638	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	uM	0.8
	16369967	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3NCCCO)nc2cc1F		CHEMBL3685637	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16369968	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCCO)c1-c1nc2ccccc2s1		CHEMBL3685636	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16369969	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(CCCO)c1-c1nc2ccccc2s1		CHEMBL3685635	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16369970	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CNCCO)cc2s1		CHEMBL3685634	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16369971	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NC2CCCC2O)c1-c1nc2ccccc2s1		CHEMBL3685633	=	IC50	nM	3500.0	CHEMBL5247	Homo sapiens	IC50	uM	3.5
	16369972	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCO)c1-c1nc2ccccc2s1		CHEMBL3685632	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16369973	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2ccncc2)c1-c1nc2ccc(S(N)(=O)=O)cc2s1		CHEMBL3685631	=	IC50	nM	50.0	CHEMBL5247	Homo sapiens	IC50	uM	0.05
	16369974	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1n[nH]c(N)c1-c1nc2ccc(S(=O)(=O)NNc3ccccc3)cc2s1		CHEMBL3730049	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16369975	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CC(=O)NNS(=O)(=O)c1ccc2nc(-c3c(C)n[nH]c3N)sc2c1		CHEMBL3732995	=	IC50	nM	30.0	CHEMBL5247	Homo sapiens	IC50	uM	0.03
	16369976	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCCN(C)C)cc2s1		CHEMBL3685629	=	IC50	nM	3200.0	CHEMBL5247	Homo sapiens	IC50	uM	3.2
	16369977	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCN(C)C)cc2s1		CHEMBL3685628	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16369978	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccncc3)cc2s1		CHEMBL3681027	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	uM	0.04
	16369979	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccc(N)cc3)cc2s1		CHEMBL3681026	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
	16369980	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3cnc[nH]3)cc2s1		CHEMBL3681025	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16369981	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCC3CC3)cc2s1		CHEMBL3685732	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	uM	0.7
	16369982	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCC(F)(F)F)cc2s1		CHEMBL3681024	=	IC50	nM	90.0	CHEMBL5247	Homo sapiens	IC50	uM	0.09
	16369983	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCN3CCOCC3)cc2s1		CHEMBL3681023	=	IC50	nM	3000.0	CHEMBL5247	Homo sapiens	IC50	uM	3.0
	16369984	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3ccc(N)cc3)cc2s1		CHEMBL3681022	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16369985	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3ccccc3)cc2s1		CHEMBL3681021	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	uM	0.8
	16369986	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccccc3)cc2s1		CHEMBL3681020	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	uM	0.8
	16369987	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc(CNS(=O)(=O)c2ccc3nc(-c4c(N)n[nH]c4C)sc3c2)cc1		CHEMBL3681019	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	uM	1.0
	16369988	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccc(Cl)cc3)cc2s1		CHEMBL3681018	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16369989	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3cccs3)cc2s1		CHEMBL3681017	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	uM	1.7
	16369990	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccc(F)cc3)cc2s1		CHEMBL3681016	=	IC50	nM	4800.0	CHEMBL5247	Homo sapiens	IC50	uM	4.8
	16369991	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COCCNS(=O)(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3681015	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
	16369992	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCO)cc2s1		CHEMBL3681014	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16369993	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(N)(=O)=O)cc2s1		CHEMBL3681013	=	IC50	nM	10.0	CHEMBL5247	Homo sapiens	IC50	uM	0.01
	16369994	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(C(N)=O)cc2s1		CHEMBL3681012	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16369995	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNS(=O)(=O)c1ccc2sc(-c3c(N)n[nH]c3C)nc2c1		CHEMBL3681011	=	IC50	nM	1900.0	CHEMBL5247	Homo sapiens	IC50	uM	1.9
	16369996	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(O)ccc2s1		CHEMBL3681010	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16369997	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(S(=O)(=O)NCc3ccncc3)cc2s1		CHEMBL3681009	=	IC50	nM	130.0	CHEMBL5247	Homo sapiens	IC50	uM	0.13
	16369998	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(S(=O)(=O)NCCO)cc2s1		CHEMBL3681008	=	IC50	nM	50.0	CHEMBL5247	Homo sapiens	IC50	uM	0.05
	16369999	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(S(N)(=O)=O)cc2s1		CHEMBL3681007	=	IC50	nM	7.0	CHEMBL5247	Homo sapiens	IC50	uM	0.007
	16370000	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2c(S(=O)(=O)NCCO)c(F)ccc2s1		CHEMBL3681006	=	IC50	nM	150.0	CHEMBL5247	Homo sapiens	IC50	uM	0.15
	16370001	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2c(F)cc(S(N)(=O)=O)cc2s1		CHEMBL3681005	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	uM	0.04
	16370002	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNS(=O)(=O)c1ccc2nc(-c3cn[nH]c3N)sc2c1		CHEMBL3681004	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	uM	0.06
	16370003	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1ccc2nc(-c3cn[nH]c3N)sc2c1		CHEMBL3681003	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370004	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Oc1ccccc1-c1n[nH]cc1-c1nc2ccccc2s1		CHEMBL3681002	=	IC50	nM	4600.0	CHEMBL5247	Homo sapiens	IC50	uM	4.6
	16370005	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]ncc1-c1nc2ccccc2s1		CHEMBL3681001	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16370006	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COC(=O)c1cccc2nc(-c3c(N)n[nH]c3C)sc12		CHEMBL3681000	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	uM	0.7
	16370007	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1cc(NS(=O)(=O)c2ccc3nc(-c4c(N)n[nH]c4C)sc3c2)nc(C)n1		CHEMBL3680999	=	IC50	nM	2600.0	CHEMBL5247	Homo sapiens	IC50	uM	2.6
	16370008	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNS(=O)(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3680998	=	IC50	nM	70.0	CHEMBL5247	Homo sapiens	IC50	uM	0.07
	16370009	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]ncc1-c1nc2ccccc2s1		CHEMBL3685679	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370010	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(N)c1-c1nc2ccccc2s1		CHEMBL3685680	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	uM	0.7
	16370011	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CN(C)CCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685681	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370012	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685682	=	IC50	nM	20.0	CHEMBL5247	Homo sapiens	IC50	uM	0.02
	16370013	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CN(C)CCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685683	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16370014	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNCCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685684	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16370015	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2ccc([N+](=O)[O-])cc2)c1-c1nc2ccccc2s1		CHEMBL3685685	=	IC50	nM	4000.0	CHEMBL5247	Homo sapiens	IC50	uM	4.0
	16370016	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(C2CC2)c1-c1nc2ccccc2s1		CHEMBL3685686	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
	16370017	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685687	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	uM	0.8
	16370018	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2ccco2)c1-c1nc2ccccc2s1		CHEMBL3685688	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16370019	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685689	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370020	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CSc1n[nH]c(N)c1-c1nc2ccccc2s1		CHEMBL3685690	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	uM	1.1
	16370021	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2ccccc2)c1-c1nc2ccccc2s1		CHEMBL3685691	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16370022	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(N2CCNCC2)c1-c1nc2ccccc2s1		CHEMBL3685692	=	IC50	nM	190.0	CHEMBL5247	Homo sapiens	IC50	uM	0.19
	16370023	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(C2CCNCC2)c1-c1nc2ccccc2s1		CHEMBL3685693	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	uM	0.06
	16370024	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2cccnc2)c1-c1nc2ccccc2s1		CHEMBL3685694	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
	16370025	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2ccncc2)c1-c1nc2ccccc2s1		CHEMBL3685695	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16370026	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(N2CCCC2)c1-c1nc2ccccc2s1		CHEMBL3685696	=	IC50	nM	3700.0	CHEMBL5247	Homo sapiens	IC50	uM	3.7
	16370027	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2cccs2)c1-c1nc2ccccc2s1		CHEMBL3685697	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16370028	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCc2ncc[nH]2)c1-c1nc2ccccc2s1		CHEMBL3685698	=	IC50	nM	2500.0	CHEMBL5247	Homo sapiens	IC50	uM	2.5
	16370029	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(/N=C/c2ncc[nH]2)c1-c1nc2ccccc2s1		CHEMBL3685699	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	uM	1.0
	16370030	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CN(C)CCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685700	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370031	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CCNCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685701	=	IC50	nM	150.0	CHEMBL5247	Homo sapiens	IC50	uM	0.15
	16370032	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685702	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	uM	0.7
	16370033	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCN2CCCC2)c1-c1nc2ccccc2s1		CHEMBL3685703	=	IC50	nM	1900.0	CHEMBL5247	Homo sapiens	IC50	uM	1.9
	16370034	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CN(C)CCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685704	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370035	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCCn2ccnc2)c1-c1nc2ccccc2s1		CHEMBL3685705	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370036	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCc2c[nH]c3ccccc23)c1-c1nc2ccccc2s1		CHEMBL3685706	=	IC50	nM	3300.0	CHEMBL5247	Homo sapiens	IC50	uM	3.3
	16370037	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCC2CCNCC2)c1-c1nc2ccccc2s1		CHEMBL3685707	=	IC50	nM	2700.0	CHEMBL5247	Homo sapiens	IC50	uM	2.7
	16370038	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCN2CCOCC2)c1-c1nc2ccccc2s1		CHEMBL3732800	=	IC50	nM	1500.0	CHEMBL5247	Homo sapiens	IC50	uM	1.5
	16370039	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3728784	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	uM	1.7
	16370040	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCc2cccnc2)c1-c1nc2ccccc2s1		CHEMBL3727684	=	IC50	nM	2900.0	CHEMBL5247	Homo sapiens	IC50	uM	2.9
	16370041	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4cccnc4Cl)n[nH]c3N)nc2cc1F		CHEMBL3685711	=	IC50	nM	3400.0	CHEMBL5247	Homo sapiens	IC50	uM	3.4
	16370042	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	NCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685712	=	IC50	nM	10.0	CHEMBL5247	Homo sapiens	IC50	uM	0.01
	16370043	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCCc2ccc(O)cc2)c1-c1nc2ccccc2s1		CHEMBL3685678	=	IC50	nM	2900.0	CHEMBL5247	Homo sapiens	IC50	uM	2.9
	16370044	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1n[nH]c(NCc2ccc(S(N)(=O)=O)cc2)c1-c1nc2ccccc2s1		CHEMBL3685677	=	IC50	nM	2900.0	CHEMBL5247	Homo sapiens	IC50	uM	2.9
	16370045	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1c(F)cc2nc(-c3c(N)n[nH]c3C)sc2c1Cl		CHEMBL3685676	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16370046	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc(Cl)c2sc(-c3c(N)n[nH]c3C)nc12		CHEMBL3685675	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	uM	1.0
	16370047	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]ncc1-c1nc2ccc([N+](=O)[O-])cc2s1		CHEMBL3685674	=	IC50	nM	3400.0	CHEMBL5247	Homo sapiens	IC50	uM	3.4
	16370048	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc2nc(-c3c(N)n[nH]c3N3CCNCC3)sc2c1		CHEMBL3685673	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370049	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685672	=	IC50	nM	340.0	CHEMBL5247	Homo sapiens	IC50	uM	0.34
	16370050	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(C)(=O)=O)cc2s1		CHEMBL3685671	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370051	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(F)cc2s1		CHEMBL3685670	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16370052	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]ncc1-c1nc2ccc(F)cc2s1		CHEMBL3685669	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370053	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN(C)C)cc2s1		CHEMBL3685668	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370054	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(CN(C)C)cc2s1		CHEMBL3685667	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	uM	0.6
	16370055	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(Cl)cc2s1		CHEMBL3685666	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370056	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(Br)cc2s1		CHEMBL3685665	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16370057	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(Br)cc2s1		CHEMBL3685664	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370058	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]ncc1-c1nc2cc(C(F)(F)F)ccc2s1		CHEMBL3685663	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	uM	1.1
	16370059	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc2sc(-c3c(N)n[nH]c3C)nc2c1		CHEMBL3685662	=	IC50	nM	3700.0	CHEMBL5247	Homo sapiens	IC50	uM	3.7
	16370060	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)ccc2s1		CHEMBL3685661	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	uM	0.04
	16370061	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3685660	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370062	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1cc2sc(-c3cn[nH]c3N)nc2cc1F		CHEMBL3685659	=	IC50	nM	50.0	CHEMBL5247	Homo sapiens	IC50	uM	0.05
	16370063	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3NCCc3cnc[nH]3)nc2cc1F		CHEMBL3685658	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370064	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4cccs4)n[nH]c3N)nc2cc1F		CHEMBL3685733	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	uM	0.7
	16370065	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccncc4)n[nH]c3N)nc2cc1F		CHEMBL3685657	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370066	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3N3CCNCC3)nc2cc1F		CHEMBL3685656	=	IC50	nM	70.0	CHEMBL5247	Homo sapiens	IC50	uM	0.07
	16370067	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccccc4)n[nH]c3N)nc2cc1F		CHEMBL3685655	=	IC50	nM	2300.0	CHEMBL5247	Homo sapiens	IC50	uM	2.3
	16370068	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3685654	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	uM	0.06
	16370069	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccno4)n[nH]c3N)nc2cc1F		CHEMBL3685653	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16370070	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccco4)n[nH]c3N)nc2cc1F		CHEMBL3685652	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	uM	0.04
	16370071	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(-c4ccc([N+](=O)[O-])o4)n[nH]c3N)nc2cc1F		CHEMBL3685651	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370072	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1ccc(-c2n[nH]c(N)c2-c2nc3ccccc3s2)cc1		CHEMBL3685713	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16370073	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3C3CC3)nc2cc1F		CHEMBL3685714	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	uM	1.0
	16370074	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2c(F)c(F)c(F)cc2s1		CHEMBL3685715	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370075	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(C(F)(F)F)ccc2s1		CHEMBL3685716	=	IC50	nM	2800.0	CHEMBL5247	Homo sapiens	IC50	uM	2.8
	16370076	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNCc1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685717	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370077	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN3CCOCC3)cc2s1		CHEMBL3685718	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370078	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN3CCCC3)cc2s1		CHEMBL3685719	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16370079	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN3CCN(C)CC3)cc2s1		CHEMBL3685720	=	IC50	nM	5000.0	CHEMBL5247	Homo sapiens	IC50	uM	5.0
	16370080	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)N3CCN(C)CC3)cc2s1		CHEMBL3685721	=	IC50	nM	4900.0	CHEMBL5247	Homo sapiens	IC50	uM	4.9
	16370081	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CC(=O)Nc1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685722	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	uM	0.4
	16370082	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CC(=O)NCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685723	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	uM	1.1
	16370083	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]nc(-c2ccc(NO)cc2)c1-c1nc2ccccc2s1		CHEMBL3685724	=	IC50	nM	1600.0	CHEMBL5247	Homo sapiens	IC50	uM	1.6
	16370084	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CC(=O)NCCNS(=O)(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685725	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	uM	0.7
	16370085	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3NCCNC(C)=O)nc2cc1F		CHEMBL3685726	=	IC50	nM	1800.0	CHEMBL5247	Homo sapiens	IC50	uM	1.8
	16370086	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	NCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685727	=	IC50	nM	20.0	CHEMBL5247	Homo sapiens	IC50	uM	0.02
	16370087	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3NCCN(C)C)nc2cc1F		CHEMBL3685728	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370088	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1cc2sc(-c3c(N)n[nH]c3NCCCN(C)C)nc2cc1F		CHEMBL3685729	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370089	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1ccc(Nc2[nH]nc(N)c2-c2nc3ccccc3s2)cc1		CHEMBL3685730	=	IC50	nM	5000.0	CHEMBL5247	Homo sapiens	IC50	uM	5.0
	16370090	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	c1ccc2sc(-c3cn[nH]c3NCCc3cnc[nH]3)nc2c1		CHEMBL3680986	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	uM	0.2
	16370091	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	NCc1[nH]ncc1-c1nc2ccccc2s1		CHEMBL3730229	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	uM	1.7
	16370092	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(CO)cc2s1		CHEMBL3680988	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	uM	0.1
	16370093	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2cc(CO)ccc2s1		CHEMBL3680989	=	IC50	nM	3700.0	CHEMBL5247	Homo sapiens	IC50	uM	3.7
	16370094	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(CO)cc2s1		CHEMBL3680990	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	uM	0.9
	16370095	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	c1ccc2sc(-c3cn[nH]c3)nc2c1		CHEMBL3680991	=	IC50	nM	1600.0	CHEMBL5247	Homo sapiens	IC50	uM	1.6
	16370096	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	NS(=O)(=O)c1ccc2nc(-c3cn[nH]c3)sc2c1		CHEMBL3680992	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	uM	0.5
	16370097	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Nc1[nH]ncc1-c1nc2cc(F)c(S(N)(=O)=O)cc2s1		CHEMBL3639798	=	IC50	nM	20.0	CHEMBL5247	Homo sapiens	IC50	uM	0.02
	16370098	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2c(F)c(F)c(F)c(S(N)(=O)=O)c2s1		CHEMBL3680993	=	IC50	nM	70.0	CHEMBL5247	Homo sapiens	IC50	uM	0.07
	16370099	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COC(=O)c1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3680994	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	uM	0.06
	16370100	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CNS(=O)(=O)c1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3680995	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	uM	0.04
	16370101	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	Cc1[nH]nc(N)c1-c1nc2ccc(C(=O)O)cc2s1		CHEMBL3680996	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	uM	1.1
	16370102	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COC(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3680997	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	uM	0.3
	16370103	CHEMBL3734121	Inhibition of full-length recombinant human GST-tagged ILK1 expressed in baculovirus infected insect Hi5 cells using CKRRRLASLR-amide as substrate after 15 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc(-c2n[nH]c(N)c2-c2nc3cc(F)c(OC)cc3s2)cc1		CHEMBL3685650	=	IC50	nM	2000.0	CHEMBL5247	Homo sapiens	IC50	uM	2.0
253014	17635964	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	c1ccc2sc(-c3cn[nH]c3NCCc3cnc[nH]3)nc2c1		CHEMBL3680986	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253015	17635965	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNc1[nH]ncc1-c1nc2ccccc2s1		CHEMBL3680987	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	nM	1700.0
253016	17635966	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(CO)cc2s1		CHEMBL3680988	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253017	17635967	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(CO)ccc2s1		CHEMBL3680989	=	IC50	nM	3700.0	CHEMBL5247	Homo sapiens	IC50	nM	3700.0
253018	17635968	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CO)cc2s1		CHEMBL3680990	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253019	17635969	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	c1ccc2sc(-c3cn[nH]c3)nc2c1		CHEMBL3680991	=	IC50	nM	1600.0	CHEMBL5247	Homo sapiens	IC50	nM	1600.0
253020	17635970	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	NS(=O)(=O)c1ccc2nc(-c3cn[nH]c3)sc2c1		CHEMBL3680992	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253021	17635971	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]ncc1-c1nc2cc(F)c(S(N)(=O)=O)cc2s1		CHEMBL3639798	=	IC50	nM	20.0	CHEMBL5247	Homo sapiens	IC50	nM	20.0
253022	17635972	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2c(F)c(F)c(F)c(S(N)(=O)=O)c2s1		CHEMBL3680993	=	IC50	nM	70.0	CHEMBL5247	Homo sapiens	IC50	nM	70.0
253023	17635973	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COC(=O)c1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3680994	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	nM	60.0
253024	17635974	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNS(=O)(=O)c1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3680995	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	nM	40.0
253025	17635975	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(C(=O)O)cc2s1		CHEMBL3680996	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	nM	1100.0
253026	17635976	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COC(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3680997	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253027	17635977	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNS(=O)(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3680998	=	IC50	nM	70.0	CHEMBL5247	Homo sapiens	IC50	nM	70.0
253028	17635978	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1cc(NS(=O)(=O)c2ccc3nc(-c4c(N)n[nH]c4C)sc3c2)nc(C)n1		CHEMBL3680999	=	IC50	nM	2600.0	CHEMBL5247	Homo sapiens	IC50	nM	2600.0
253029	17635979	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COC(=O)c1cccc2nc(-c3c(N)n[nH]c3C)sc12		CHEMBL3681000	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	nM	700.0
253030	17635980	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]ncc1-c1nc2ccccc2s1		CHEMBL3681001	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253031	17635981	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Oc1ccccc1-c1n[nH]cc1-c1nc2ccccc2s1		CHEMBL3681002	=	IC50	nM	4600.0	CHEMBL5247	Homo sapiens	IC50	nM	4600.0
253032	17635982	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1ccc2nc(-c3cn[nH]c3N)sc2c1		CHEMBL3681003	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253033	17635983	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNS(=O)(=O)c1ccc2nc(-c3cn[nH]c3N)sc2c1		CHEMBL3681004	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	nM	60.0
253034	17635984	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2c(F)cc(S(N)(=O)=O)cc2s1		CHEMBL3681005	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	nM	40.0
253035	17635985	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2c(S(=O)(=O)NCCO)c(F)ccc2s1		CHEMBL3681006	=	IC50	nM	150.0	CHEMBL5247	Homo sapiens	IC50	nM	150.0
253036	17635986	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(S(N)(=O)=O)cc2s1		CHEMBL3681007	=	IC50	nM	7.0	CHEMBL5247	Homo sapiens	IC50	nM	7.0
253037	17635987	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(S(=O)(=O)NCCO)cc2s1		CHEMBL3681008	=	IC50	nM	50.0	CHEMBL5247	Homo sapiens	IC50	nM	50.0
253038	17635988	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(S(=O)(=O)NCc3ccncc3)cc2s1		CHEMBL3681009	=	IC50	nM	130.0	CHEMBL5247	Homo sapiens	IC50	nM	130.0
253039	17635989	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(O)ccc2s1		CHEMBL3681010	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253040	17635990	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNS(=O)(=O)c1ccc2sc(-c3c(N)n[nH]c3C)nc2c1		CHEMBL3681011	=	IC50	nM	1900.0	CHEMBL5247	Homo sapiens	IC50	nM	1900.0
253041	17635991	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(C(N)=O)cc2s1		CHEMBL3681012	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253042	17635992	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(N)(=O)=O)cc2s1		CHEMBL3681013	=	IC50	nM	10.0	CHEMBL5247	Homo sapiens	IC50	nM	10.0
253043	17635993	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCO)cc2s1		CHEMBL3681014	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253044	17635994	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COCCNS(=O)(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3681015	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	nM	600.0
253045	17635995	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccc(F)cc3)cc2s1		CHEMBL3681016	=	IC50	nM	4800.0	CHEMBL5247	Homo sapiens	IC50	nM	4800.0
253046	17635996	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3cccs3)cc2s1		CHEMBL3681017	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	nM	1700.0
253047	17635997	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccc(Cl)cc3)cc2s1		CHEMBL3681018	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253048	17635998	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc(CNS(=O)(=O)c2ccc3nc(-c4c(N)n[nH]c4C)sc3c2)cc1		CHEMBL3681019	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	nM	1000.0
253049	17635999	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccccc3)cc2s1		CHEMBL3681020	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	nM	800.0
253050	17636000	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3ccccc3)cc2s1		CHEMBL3681021	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	nM	800.0
253051	17636001	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3ccc(N)cc3)cc2s1		CHEMBL3681022	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253052	17636002	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCN3CCOCC3)cc2s1		CHEMBL3681023	=	IC50	nM	3000.0	CHEMBL5247	Homo sapiens	IC50	nM	3000.0
253053	17636003	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCC(F)(F)F)cc2s1		CHEMBL3681024	=	IC50	nM	90.0	CHEMBL5247	Homo sapiens	IC50	nM	90.0
253054	17636004	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCC3CC3)cc2s1		CHEMBL3685732	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	nM	700.0
253055	17636005	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCc3cnc[nH]3)cc2s1		CHEMBL3681025	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253056	17636006	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccc(N)cc3)cc2s1		CHEMBL3681026	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	nM	600.0
253057	17636007	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCc3ccncc3)cc2s1		CHEMBL3681027	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	nM	40.0
253058	17636008	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCN(C)C)cc2s1		CHEMBL3685628	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253059	17636009	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NCCCN(C)C)cc2s1		CHEMBL3685629	=	IC50	nM	3200.0	CHEMBL5247	Homo sapiens	IC50	nM	3200.0
253060	17636010	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)NNNc3ccccc3)cc2s1		CHEMBL3685630	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253061	17636011	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2ccncc2)c1-c1nc2ccc(S(N)(=O)=O)cc2s1		CHEMBL3685631	=	IC50	nM	50.0	CHEMBL5247	Homo sapiens	IC50	nM	50.0
253062	17636012	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCO)c1-c1nc2ccccc2s1		CHEMBL3685632	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253063	17636013	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NC2CCCC2O)c1-c1nc2ccccc2s1		CHEMBL3685633	=	IC50	nM	3500.0	CHEMBL5247	Homo sapiens	IC50	nM	3500.0
253064	17636014	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CNCCO)cc2s1		CHEMBL3685634	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253065	17636015	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(CCCO)c1-c1nc2ccccc2s1		CHEMBL3685635	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253066	17636016	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCCO)c1-c1nc2ccccc2s1		CHEMBL3685636	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253067	17636017	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3NCCCO)nc2cc1F		CHEMBL3685637	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253068	17636018	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CNc3cccc(S(N)(=O)=O)c3)cc2s1		CHEMBL3685638	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	nM	800.0
253069	17636019	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CCc1cc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)cc1O		CHEMBL3685639	=	IC50	nM	1900.0	CHEMBL5247	Homo sapiens	IC50	nM	1900.0
253070	17636020	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)c1		CHEMBL1368744	=	IC50	nM	3300.0	CHEMBL5247	Homo sapiens	IC50	nM	3300.0
253071	17636021	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)cc1		CHEMBL3685640	=	IC50	nM	3400.0	CHEMBL5247	Homo sapiens	IC50	nM	3400.0
253072	17636022	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2c(F)cccc2s1		CHEMBL3685641	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253073	17636023	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(CCCCO)c1-c1nc2ccccc2s1		CHEMBL3685642	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	nM	1000.0
253074	17636024	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCCCO)c1-c1nc2ccccc2s1		CHEMBL3685643	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	nM	1700.0
253075	17636025	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCCC(=O)O)c1-c1nc2ccccc2s1		CHEMBL3685644	=	IC50	nM	4300.0	CHEMBL5247	Homo sapiens	IC50	nM	4300.0
253076	17636026	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(Nc2ccc(S(=O)(=O)Nc3nccs3)cc2)c1-c1nc2ccccc2s1		CHEMBL3685645	=	IC50	nM	3500.0	CHEMBL5247	Homo sapiens	IC50	nM	3500.0
253077	17636027	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccccc4F)n[nH]c3N)nc2cc1F		CHEMBL3639845	=	IC50	nM	4000.0	CHEMBL5247	Homo sapiens	IC50	nM	4000.0
253078	17636028	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3C3CC3c3ccccc3)nc2cc1F		CHEMBL3685646	=	IC50	nM	2100.0	CHEMBL5247	Homo sapiens	IC50	nM	2100.0
253079	17636029	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4cccc(F)c4)n[nH]c3N)nc2cc1F		CHEMBL3685647	=	IC50	nM	2300.0	CHEMBL5247	Homo sapiens	IC50	nM	2300.0
253080	17636030	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4cccc([N+](=O)[O-])c4)n[nH]c3N)nc2cc1F		CHEMBL3685648	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253081	17636031	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccc(F)cc4)n[nH]c3N)nc2cc1F		CHEMBL3685649	=	IC50	nM	2400.0	CHEMBL5247	Homo sapiens	IC50	nM	2400.0
253082	17636032	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc(-c2n[nH]c(N)c2-c2nc3cc(F)c(OC)cc3s2)cc1		CHEMBL3685650	=	IC50	nM	2000.0	CHEMBL5247	Homo sapiens	IC50	nM	2000.0
253083	17636033	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccc([N+](=O)[O-])o4)n[nH]c3N)nc2cc1F		CHEMBL3685651	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253084	17636034	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccco4)n[nH]c3N)nc2cc1F		CHEMBL3685652	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	nM	40.0
253085	17636035	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccno4)n[nH]c3N)nc2cc1F		CHEMBL3685653	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253086	17636036	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3685654	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	nM	60.0
253087	17636037	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccccc4)n[nH]c3N)nc2cc1F		CHEMBL3685655	=	IC50	nM	2300.0	CHEMBL5247	Homo sapiens	IC50	nM	2300.0
253088	17636038	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3N3CCNCC3)nc2cc1F		CHEMBL3685656	=	IC50	nM	70.0	CHEMBL5247	Homo sapiens	IC50	nM	70.0
253089	17636039	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4ccncc4)n[nH]c3N)nc2cc1F		CHEMBL3685657	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253090	17636040	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4cccs4)n[nH]c3N)nc2cc1F		CHEMBL3685733	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	nM	700.0
253091	17636041	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3NCCc3cnc[nH]3)nc2cc1F		CHEMBL3685658	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253092	17636042	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1cc2sc(-c3cn[nH]c3N)nc2cc1F		CHEMBL3685659	=	IC50	nM	50.0	CHEMBL5247	Homo sapiens	IC50	nM	50.0
253093	17636043	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1cc2sc(-c3c(N)n[nH]c3C)nc2cc1F		CHEMBL3685660	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253094	17636044	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)ccc2s1		CHEMBL3685661	=	IC50	nM	40.0	CHEMBL5247	Homo sapiens	IC50	nM	40.0
253095	17636045	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc2sc(-c3c(N)n[nH]c3C)nc2c1		CHEMBL3685662	=	IC50	nM	3700.0	CHEMBL5247	Homo sapiens	IC50	nM	3700.0
253096	17636046	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]ncc1-c1nc2cc(C(F)(F)F)ccc2s1		CHEMBL3685663	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	nM	1100.0
253097	17636047	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(Br)cc2s1		CHEMBL3685664	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253098	17636048	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(Br)cc2s1		CHEMBL3685665	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253099	17636049	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(Cl)cc2s1		CHEMBL3685666	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253100	17636050	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(F)c(CN(C)C)cc2s1		CHEMBL3685667	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	nM	600.0
253101	17636051	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN(C)C)cc2s1		CHEMBL3685668	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253102	17636052	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]ncc1-c1nc2ccc(F)cc2s1		CHEMBL3685669	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253103	17636053	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(F)cc2s1		CHEMBL3685670	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253104	17636054	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(C)(=O)=O)cc2s1		CHEMBL3685671	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253105	17636055	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685672	=	IC50	nM	340.0	CHEMBL5247	Homo sapiens	IC50	nM	340.0
253106	17636056	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc2nc(-c3c(N)n[nH]c3N3CCNCC3)sc2c1		CHEMBL3685673	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253107	17636057	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]ncc1-c1nc2ccc([N+](=O)[O-])cc2s1		CHEMBL3685674	=	IC50	nM	3400.0	CHEMBL5247	Homo sapiens	IC50	nM	3400.0
253108	17636058	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc(Cl)c2sc(-c3c(N)n[nH]c3C)nc12		CHEMBL3685675	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	nM	1000.0
253109	17636059	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1c(F)cc2nc(-c3c(N)n[nH]c3C)sc2c1Cl		CHEMBL3685676	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253110	17636060	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCc2ccc(S(N)(=O)=O)cc2)c1-c1nc2ccccc2s1		CHEMBL3685677	=	IC50	nM	2900.0	CHEMBL5247	Homo sapiens	IC50	nM	2900.0
253111	17636061	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCc2ccc(O)cc2)c1-c1nc2ccccc2s1		CHEMBL3685678	=	IC50	nM	2900.0	CHEMBL5247	Homo sapiens	IC50	nM	2900.0
253112	17636062	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]ncc1-c1nc2ccccc2s1		CHEMBL3685679	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253113	17636063	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(N)c1-c1nc2ccccc2s1		CHEMBL3685680	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	nM	700.0
253114	17636064	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CN(C)CCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685681	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253115	17636065	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685682	=	IC50	nM	20.0	CHEMBL5247	Homo sapiens	IC50	nM	20.0
253116	17636066	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CN(C)CCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685683	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253117	17636067	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNCCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685684	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253118	17636068	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2ccc([N+](=O)[O-])cc2)c1-c1nc2ccccc2s1		CHEMBL3685685	=	IC50	nM	4000.0	CHEMBL5247	Homo sapiens	IC50	nM	4000.0
253119	17636069	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(C2CC2)c1-c1nc2ccccc2s1		CHEMBL3685686	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	nM	600.0
253120	17636070	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685687	=	IC50	nM	800.0	CHEMBL5247	Homo sapiens	IC50	nM	800.0
253121	17636071	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2ccco2)c1-c1nc2ccccc2s1		CHEMBL3685688	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253122	17636072	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685689	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253123	17636073	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CSc1n[nH]c(N)c1-c1nc2ccccc2s1		CHEMBL3685690	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	nM	1100.0
253124	17636074	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2ccccc2)c1-c1nc2ccccc2s1		CHEMBL3685691	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253125	17636075	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(N2CCNCC2)c1-c1nc2ccccc2s1		CHEMBL3685692	=	IC50	nM	190.0	CHEMBL5247	Homo sapiens	IC50	nM	190.0
253126	17636076	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(C2CCNCC2)c1-c1nc2ccccc2s1		CHEMBL3685693	=	IC50	nM	60.0	CHEMBL5247	Homo sapiens	IC50	nM	60.0
253127	17636077	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2cccnc2)c1-c1nc2ccccc2s1		CHEMBL3685694	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	nM	600.0
253128	17636078	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2ccncc2)c1-c1nc2ccccc2s1		CHEMBL3685695	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253129	17636079	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(N2CCCC2)c1-c1nc2ccccc2s1		CHEMBL3685696	=	IC50	nM	3700.0	CHEMBL5247	Homo sapiens	IC50	nM	3700.0
253130	17636080	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2cccs2)c1-c1nc2ccccc2s1		CHEMBL3685697	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253131	17636081	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCc2ncc[nH]2)c1-c1nc2ccccc2s1		CHEMBL3685698	=	IC50	nM	2500.0	CHEMBL5247	Homo sapiens	IC50	nM	2500.0
253132	17636082	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(/N=C/c2ncc[nH]2)c1-c1nc2ccccc2s1		CHEMBL3685699	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	nM	1000.0
253133	17636083	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CN(C)CCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685700	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253134	17636084	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CCNCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685701	=	IC50	nM	150.0	CHEMBL5247	Homo sapiens	IC50	nM	150.0
253135	17636085	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685702	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	nM	700.0
253136	17636086	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCN2CCCC2)c1-c1nc2ccccc2s1		CHEMBL3685703	=	IC50	nM	1900.0	CHEMBL5247	Homo sapiens	IC50	nM	1900.0
253137	17636087	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CN(C)CCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685704	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253138	17636088	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCCn2ccnc2)c1-c1nc2ccccc2s1		CHEMBL3685705	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253139	17636089	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCCc2c[nH]c3ccccc23)c1-c1nc2ccccc2s1		CHEMBL3685706	=	IC50	nM	3300.0	CHEMBL5247	Homo sapiens	IC50	nM	3300.0
253140	17636090	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1n[nH]c(NCC2CCNCC2)c1-c1nc2ccccc2s1		CHEMBL3685707	=	IC50	nM	2700.0	CHEMBL5247	Homo sapiens	IC50	nM	2700.0
253141	17636091	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1nn(CCN2CCOCC2)c(N)c1-c1nc2ccccc2s1		CHEMBL3685708	=	IC50	nM	1500.0	CHEMBL5247	Homo sapiens	IC50	nM	1500.0
253142	17636092	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CCn1nc(N)c(-c2nc3ccccc3s2)c1N		CHEMBL3685709	=	IC50	nM	1700.0	CHEMBL5247	Homo sapiens	IC50	nM	1700.0
253143	17636093	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1nn(Cc2cccnc2)c(N)c1-c1nc2ccccc2s1		CHEMBL3685710	=	IC50	nM	2900.0	CHEMBL5247	Homo sapiens	IC50	nM	2900.0
253144	17636094	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(-c4cccnc4Cl)n[nH]c3N)nc2cc1F		CHEMBL3685711	=	IC50	nM	3400.0	CHEMBL5247	Homo sapiens	IC50	nM	3400.0
253145	17636095	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	NCCCc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685712	=	IC50	nM	10.0	CHEMBL5247	Homo sapiens	IC50	nM	10.0
253146	17636096	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1ccc(-c2n[nH]c(N)c2-c2nc3ccccc3s2)cc1		CHEMBL3685713	=	IC50	nM	100.0	CHEMBL5247	Homo sapiens	IC50	nM	100.0
253147	17636097	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3C3CC3)nc2cc1F		CHEMBL3685714	=	IC50	nM	1000.0	CHEMBL5247	Homo sapiens	IC50	nM	1000.0
253148	17636098	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2c(F)c(F)c(F)cc2s1		CHEMBL3685715	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253149	17636099	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2cc(C(F)(F)F)ccc2s1		CHEMBL3685716	=	IC50	nM	2800.0	CHEMBL5247	Homo sapiens	IC50	nM	2800.0
253150	17636100	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CNCc1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685717	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253151	17636101	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN3CCOCC3)cc2s1		CHEMBL3685718	=	IC50	nM	500.0	CHEMBL5247	Homo sapiens	IC50	nM	500.0
253152	17636102	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN3CCCC3)cc2s1		CHEMBL3685719	=	IC50	nM	900.0	CHEMBL5247	Homo sapiens	IC50	nM	900.0
253153	17636103	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(CN3CCN(C)CC3)cc2s1		CHEMBL3685720	=	IC50	nM	5000.0	CHEMBL5247	Homo sapiens	IC50	nM	5000.0
253154	17636104	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Cc1[nH]nc(N)c1-c1nc2ccc(S(=O)(=O)N3CCN(C)CC3)cc2s1		CHEMBL3685721	=	IC50	nM	4900.0	CHEMBL5247	Homo sapiens	IC50	nM	4900.0
253155	17636105	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CC(=O)Nc1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685722	=	IC50	nM	400.0	CHEMBL5247	Homo sapiens	IC50	nM	400.0
253156	17636106	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CC(=O)NCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685723	=	IC50	nM	1100.0	CHEMBL5247	Homo sapiens	IC50	nM	1100.0
253157	17636107	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1[nH]nc(-c2ccc(NO)cc2)c1-c1nc2ccccc2s1		CHEMBL3685724	=	IC50	nM	1600.0	CHEMBL5247	Homo sapiens	IC50	nM	1600.0
253158	17636108	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	CC(=O)NCCNS(=O)(=O)c1ccc2nc(-c3c(N)n[nH]c3C)sc2c1		CHEMBL3685725	=	IC50	nM	700.0	CHEMBL5247	Homo sapiens	IC50	nM	700.0
253159	17636109	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3NCCNC(C)=O)nc2cc1F		CHEMBL3685726	=	IC50	nM	1800.0	CHEMBL5247	Homo sapiens	IC50	nM	1800.0
253160	17636110	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	NCCNc1[nH]nc(N)c1-c1nc2ccccc2s1		CHEMBL3685727	=	IC50	nM	20.0	CHEMBL5247	Homo sapiens	IC50	nM	20.0
253161	17636111	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3NCCN(C)C)nc2cc1F		CHEMBL3685728	=	IC50	nM	300.0	CHEMBL5247	Homo sapiens	IC50	nM	300.0
253162	17636112	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1cc2sc(-c3c(N)n[nH]c3NCCCN(C)C)nc2cc1F		CHEMBL3685729	=	IC50	nM	200.0	CHEMBL5247	Homo sapiens	IC50	nM	200.0
253163	17636113	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	Nc1ccc(Nc2[nH]nc(N)c2-c2nc3ccccc3s2)cc1		CHEMBL3685730	=	IC50	nM	5000.0	CHEMBL5247	Homo sapiens	IC50	nM	5000.0
253164	17636114	CHEMBL3705203	In Vitro Ezyme Assay: 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.	B	COc1ccc2nc(-c3c(N)n[nH]c3NCCc3cnc[nH]3)sc2c1		CHEMBL3685731	=	IC50	nM	600.0	CHEMBL5247	Homo sapiens	IC50	nM	600.0
Inactive	17907332	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907333	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907334	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907335	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907336	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907337	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907338	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907339	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907340	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907341	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907342	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907343	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907344	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907345	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907346	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907347	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907348	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907349	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907350	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907351	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907352	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907353	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907354	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907355	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907356	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907357	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907358	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907359	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907360	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907361	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907362	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907363	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907364	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907365	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907366	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907367	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907368	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907369	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907370	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907371	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907372	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907373	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907374	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907375	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907376	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907377	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907378	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907379	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907380	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907381	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907382	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907383	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907384	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907385	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907386	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907387	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907388	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907389	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907390	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907391	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907392	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907393	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907394	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907395	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907396	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907397	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907398	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907399	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907400	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907401	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907402	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907403	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907404	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907405	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907406	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17907407	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	1329.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	1329.0
Inactive	17907408	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907409	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907410	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907411	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907412	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907413	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907414	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907415	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907416	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907417	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907418	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907419	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907420	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907421	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907422	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907423	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907424	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907425	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907426	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907427	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907428	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907429	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907430	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907431	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907432	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907433	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907434	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907435	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907436	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907437	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907438	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907439	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907440	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907441	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907442	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17907443	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	=	Kd	nM	32.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	32.0
Inactive	17907444	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907445	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907446	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907447	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907448	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907449	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907450	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907451	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907452	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907453	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907454	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907455	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907456	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907457	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907458	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907459	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907460	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907461	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907462	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907463	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907464	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907465	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907466	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907467	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907468	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907469	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907470	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907471	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907472	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907473	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907474	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907475	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907476	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907477	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907478	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17907479	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	20.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	20.0
Inactive	17907480	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907481	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907482	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907483	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907484	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907485	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907486	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907487	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907488	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907489	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907490	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907491	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907492	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907493	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907494	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907495	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907496	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907497	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907498	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907499	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907500	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907501	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907502	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907503	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907504	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907505	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907506	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907507	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907508	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907509	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907510	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907511	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907512	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907513	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907514	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907515	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907516	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907517	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907518	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907519	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907520	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907521	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907522	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907523	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907524	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907525	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907526	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907527	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907528	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907529	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907530	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907531	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907532	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907533	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907534	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907535	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907536	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907537	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907538	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907539	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907540	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907541	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907542	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907543	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907544	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907545	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907546	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907547	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17907548	CHEMBL3991737	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5247	Homo sapiens	Kd apparent	nM	30000.0
	18153095	CHEMBL4034341	Inhibition of ILK Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	4.0	CHEMBL5247	Homo sapiens	INH	%	4.0
	18153307	CHEMBL4034342	Inhibition of ILK protein kinase domain (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	>	Inhibition	%	35.0	CHEMBL5247	Homo sapiens	INH	%	35.0
	18211587	CHEMBL4045699	Inhibition of ILK Protein Kinase Domain (ISMADVKFSFQCPGR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	7.7	CHEMBL5247	Homo sapiens	INH	%	7.7
	18211601	CHEMBL4045698	Inhibition of ILK conserved Lys1 (WQGNDIVVKVLK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	10.4	CHEMBL5247	Homo sapiens	INH	%	10.4
	18211843	CHEMBL4045939	Inhibition of ILK conserved Lys1 (WQGNDIVVKVLK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	7.6	CHEMBL5247	Homo sapiens	INH	%	7.6
	18211844	CHEMBL4045940	Inhibition of ILK Protein Kinase Domain (ISMADVKFSFQCPGR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	2.5	CHEMBL5247	Homo sapiens	INH	%	2.5
	18274953	CHEMBL4118363	Inhibition of ILK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled WQGNDIVVKVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-28.6	CHEMBL5247	Homo sapiens	INH	%	-28.6
	18274954	CHEMBL4118363	Inhibition of ILK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled WQGNDIVVKVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-25.7	CHEMBL5247	Homo sapiens	INH	%	-25.7
	18274955	CHEMBL4118363	Inhibition of ILK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled WQGNDIVVKVLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-28.5	CHEMBL5247	Homo sapiens	INH	%	-28.5
	23120461	CHEMBL4804393	Inhibition of ILK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	1600.0	CHEMBL5247	Homo sapiens	IC50	uM	1.6
	23120462	CHEMBL4804393	Inhibition of ILK in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-5800.0	CHEMBL5247	Homo sapiens	IC50	uM	-5.8
	23120463	CHEMBL4804393	Inhibition of ILK in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	51200.0	CHEMBL5247	Homo sapiens	IC50	uM	51.2
	23120464	CHEMBL4804393	Inhibition of ILK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-31300.0	CHEMBL5247	Homo sapiens	IC50	uM	-31.3
	23120465	CHEMBL4804393	Inhibition of ILK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-35000.0	CHEMBL5247	Homo sapiens	IC50	uM	-35.0
	23120466	CHEMBL4804393	Inhibition of ILK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-19000.0	CHEMBL5247	Homo sapiens	IC50	uM	-19.0
	23121500	CHEMBL4804575	Inhibition of ILK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL5247	Homo sapiens	INH	%	0.0
	23121501	CHEMBL4804575	Inhibition of ILK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL5247	Homo sapiens	INH	%	0.0
	23121502	CHEMBL4804575	Inhibition of ILK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	50.0	CHEMBL5247	Homo sapiens	INH	%	50.0
	23121503	CHEMBL4804575	Inhibition of ILK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5247	Homo sapiens	INH	%	0.0
	23121504	CHEMBL4804575	Inhibition of ILK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5247	Homo sapiens	INH	%	0.0
	23121505	CHEMBL4804575	Inhibition of ILK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL5247	Homo sapiens	INH	%	0.0
Not Active	23238582	CHEMBL4828626	Modulation of ILK in human mesangial cells assessed as reduction in GSK-3beta phosphorylation at ser9 residue at 50 uM measured upto 90 mins by Western blot analysis	B	COC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(C)C		CHEMBL4876512		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238583	CHEMBL4828627	Modulation of ILK in human mesangial cells assessed as reduction in AKT phosphorylation at Ser473 residue at 50 uM measured upto 90 mins by Western blot analysis	B	COC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(C)C		CHEMBL4876512		Activity			CHEMBL5247	Homo sapiens	Activity		
Active	23238586	CHEMBL4828630	Inhibition of ILK (unknown origin)	B	COC(=O)[C@@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(C)C		CHEMBL4848988		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Active	23238587	CHEMBL4828630	Inhibition of ILK (unknown origin)	B	COC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O		CHEMBL4866639		Inhibition	%		CHEMBL5247	Homo sapiens	INH		
Not Active	23238588	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(C)C		CHEMBL4847988		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238589	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(C)=O)C(C)C		CHEMBL4871263		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238590	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(C)C		CHEMBL4876512		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238591	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O		CHEMBL4851151		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238592	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O		CHEMBL4853310		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238593	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(C)C		CHEMBL4848988		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238594	CHEMBL4828631	Induction of ILK (unknown origin)	B	COC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O		CHEMBL4866639		Activity			CHEMBL5247	Homo sapiens	Activity		
Not Active	23238595	CHEMBL4828631	Induction of ILK (unknown origin)	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C		CHEMBL4849631		Activity			CHEMBL5247	Homo sapiens	Activity		
